Evidence map›Paper›PMID 21552549›Full record

ArticlePloS one2011

The genetic association of variants in CD6, TNFRSF1A and IRF8 to multiple sclerosis: a multicenter case-control study.

International Multiple Sclerosis Genetics Consortium

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 75 citations in OpenAlex.

  1. The Impact ofInternational journal of molecular sciences · 2024
    Article
  2. Article
  3. Article
  4. Elevated TNF-α Leads to Neural Circuit Instability in the Absence of Interferon Regulatory Factor 8.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Genome-wide association studies of multiple sclerosis.Clinical & translational immunology · 2018
    Review
  14. CD318 is a ligand for CD6.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  15. CD6 as a potential target for treating multiple sclerosis.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

International Multiple Sclerosis Genetics Consortium
Institute for Molecular Medicine Finland · FI

Funding

A Haplotype Map for Multiple SclerosisR01NS049477 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HAUSER, STEPHEN L · 2005 to 2014
$15.3M
Exploring the consequences of the TNFRSF1A susceptibility allele for MSR01NS067305 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI DE JAGER, PHILIP L · 2009 to 2011
$1.2M
Genetic loci predisposing to multiple sclerosis (MS)R01NS043559 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI PELTONEN, LEENA · 2002 to 2005
$984k
NINDS NIH HHS R01 NS043559NINDS NIH HHS R01 NS049477NINDS NIH HHS R01 NS067305NINDS NIH HHS R01 NS 43559Wellcome TrustWellcome Trust 089061/Z/09/Z
6 · The paper itself

Abstract

backgroundIn the recently published meta-analysis of multiple sclerosis genome-wide association studies De Jager et al. identified three single nucleotide polymorphisms associated to MS: rs17824933 (CD6), rs1800693 (TNFRSF1A) and rs17445836 (61.5 kb from IRF8). To refine our understanding of these associations we sought to replicate these findings in a large more extensive independent sample set of 11 populations of European origin. PRINCIPAL

findingsWe calculated individual and combined associations using a meta-analysis method by Kazeem and Farral (2005). We confirmed the association of rs1800693 in TNFRSF1A (p 4.19 × 10-7, OR 1.12, 7,665 cases, 8,051 controls) and rs17445836 near IRF8 (p 5.35 × 10-10, OR 0.84, 6,895 cases, 7,580 controls and 596 case-parent trios) The SNP rs17824933 in CD6 also showed nominally significant evidence for association (p 2.19 × 10-5, OR 1.11, 8,047 cases, 9,174 controls, 604 case-parent trios).

conclusionsVariants in TNFRSF1A and in the vicinity of IRF8 were confirmed to be associated in these independent cohorts, which supports the role of these loci in etiology of multiple sclerosis. The variant in CD6 reached genome-wide significance after combining the data with the original meta-analysis. Fine mapping is required to identify the predisposing variants in the loci and future functional studies will refine their molecular role in MS pathogenesis.

Indexed as

Antigens, CDAntigens, Differentiation, T-LymphocyteCase-Control StudiesHumansInterferon Regulatory Factor-8Interferon Regulatory FactorsMultiple SclerosisPolymorphism, Single NucleotideReceptors, Tumor Necrosis Factor, Type IAntigens, CDAntigens, Differentiation, T-LymphocyteCD6 antigenInterferon Regulatory Factor-8Interferon Regulatory FactorsReceptors, Tumor Necrosis Factor, Type ITNFRSF1A protein, human

Identifiers

PMID21552549
PMCPMC3084233
OpenAlexW2106624849

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.